Protein damage by photo-activated Zn(II) N-alkylpyridylporphyrins

Amino Acids

Volumn 42, Issue 1, 2012, Pages 117-128

  Benov, Ludmil ^a   Craik, James ^a   Batinic Haberle, Ines ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

And para isomeric Zn(II) N alkylpyridyl porphyrins; Hematoporphyrin D (HpD); Meta; Ortho; Oxidative protein modification; Photodynamic therapy; Photosensitizer

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMATOPORPHYRIN; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ZINC MESO TETRAKIS(N HEXYLPYRIDINIUM 2 YL)PORPHYRIN; ZINC MESO TETRAKIS(N METHYLPYRIDINIUM 2 YL)PORPHYRIN; ZINC MESO TETRAKIS(N METHYLPYRIDINIUM 3 YL)PORPHYRIN; ZINC MESO TETRAKIS(N METHYLPYRIDINIUM 43 YL)PORPHYRIN; METALLOPORPHYRIN; PROTEIN; ZINC;

CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; CONFERENCE PAPER; DRUG BINDING; DRUG EFFECT; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; LIPOPHILICITY; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DAMAGE; PROTEIN MODIFICATION; CHEMISTRY; METABOLISM; REVIEW;

HUMANS; METALLOPORPHYRINS; PHOTOSENSITIZING AGENTS; PROTEINS; ZINC;

EID: 84858155372     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0640-1     Document Type: Conference Paper

References (66)

1. Al-Mutairi DA, Craik JD, Batinic-Haberle I, Benov LT (2006) Photosensitizing action of isomeric zinc N-methylpyridyl porphyrins in human carcinoma cells. Free Radic Res 40:477-483
2. Al-Mutairi DA, Craik JD, Batinic-Haberle I, Benov LT (2007a) Inactivation of metabolic enzymes by photo-treatment with zinc meta N- methylpyridylporphyrin. Biochim Biophys Acta 1770:1520-1527 (Pubitemid 47503554)
3. Al-Mutairi DA, Craik JD, Batinic-Haberle I, Benov LT (2007b) Induction of oxidative cell damage by photo-treatment with zinc N-methylpyridylporphyrin. Free Radic Res 41:89-96 (Pubitemid 44896878)
4. Atlante A, Passarella S, Quagliariello E, Moreno G, Salet C (1989) Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: inhibition of ADP/ATP translocator. J Photochem Photobiol B 4:35-46
5. Batinic-Haberle I, Benov L, Spasojevic I, Fridovich I (1998) The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium- 2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J Biol Chem 273:24521-24528 (Pubitemid 28454947)
6. Batinic-Haberle I, Reboucas J, Benov L, Spasojevic I (2010a) Chemistry, biology and medical effects of water-soluble porphyrins. In: Kadish K, Smith K, Guillard R (eds) Handbook of porphyrin science, vol XI, World Scientific (in press)
7. Batinic-Haberle I, Spasojevic I, Piganelli JD, Reboucas JS, Dewhirst MW, Vujaskovic Z, Warner DS, St Clair DK (2010b) The remarkable potency of Mn-porphyrins in treating oxidative stress injuries arises from their differential tissue and subcellular distribution and interaction with redox-based transcription factors. In: 6th International conference on porphyrins and phthalocyanines, ICPP-6, New Mexico
8. Benov L, Batinic-Haberle I, Spasojevic I, Fridovich I (2002) Isomeric N-alkylpyridylporphyrins and their Zn(II) complexes: inactive as SOD mimics but powerful photosensitizers. Arch Biochem Biophys 402:159-165 (Pubitemid 34848632)
9. Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474-482 (Pubitemid 23199849)
10. Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127-152 (Pubitemid 41510276)
11. Boros LG, Lee PW, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS, Ellison EC (1998) Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med Hypotheses 50:55-59 (Pubitemid 28046401)
12. Boyle RW,DolphinD(1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 64:469-485 (Pubitemid 27039801)
13. Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photodynamic therapy: Part one-Photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 1:279-293 (Pubitemid 40460316)
14. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535-545 (Pubitemid 43980542)
15. Chen B, Pogue BW, Hoopes PJ, Hasan T (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16:279-305
16. Coppola A, Viggiani E, Salzarulo L, Rasile G (1980) Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light. Am J Pathol 99:175-192
17. Davies MJ (2003) Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 305:761-770 (Pubitemid 36579294)
18. Davies MJ (2004) Reactive species formed on proteins exposed to singlet oxygen. Photochem Photobiol Sci 3:17-25 (Pubitemid 38842660)
19. Davies MJ (2005) The oxidative environment and protein damage. Biochim Biophys Acta 1703:93-109 (Pubitemid 40170433)
20. Donnelly RF, McCarron PA, Tunney MM (2008) Antifungal photodynamic therapy. Microbiol Res 163:1-12 (Pubitemid 350251183)
21. Dummin H, Cernay T, Zimmermann HW (1997) Selective photosensitization of mitochondria in HeLa cells by cationic Zn(II)phthalocyanines with lipophilic side-chains. J Photochem Photobiol B 37:219-229 (Pubitemid 27117021)
22. Dutta AK, Sabirov RZ, Uramoto H, Okada Y (2004) Role of ATPconductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions. J Physiol 559:799-812 (Pubitemid 39276169)
23. Escobar JA, Rubio MA, Lissi EA (1996) SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Radic Biol Med 20:285-290 (Pubitemid 26077850)
24. Ferrer-Sueta G, Radi R (2009) Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 4:161-177
25. Foote CS (1991) Definition of type I and type II photosensitized oxidation. Photochem Photobiol 54:659
26. Fridovich I (1998) Oxygen toxicity: a radical explanation. J Exp Biol 201:1203-1209 (Pubitemid 28278324)
27. Gomyo T, Fujimaki M (1970) Studies on changes in protein by dye sensitized photooxidation. Part 3: On the photodecomposition products of lysozyme. Agric Biol Chem 34:302-309
28. Groves JT (1999) Peroxynitrite: reactive, invasive and enigmatic. Curr Opin Chem Biol 3:226-235 (Pubitemid 29145790)
29. Hazama A, Fan HT, Abdullaev I, Maeno E, Tanaka S, Ando- Akatsuka Y, Okada Y (2000) Swelling-activated, cystic fibrosis transmembrane conductance regulator-augmented ATP release and Cl-conductances in murine C127 cells. J Physiol 1:1-11 (Pubitemid 30135816)
30. Hilf R (2007) Mitochondria are targets of photodynamic therapy. J Bioenerg Biomembr 39:85-89 (Pubitemid 46877177)
31. Hilf R, Warne NW, Smail DB, Gibson SL (1984) Photodynamic inactivation of selected intracellular enzymes by hematoporphyrin derivative and their relationship to tumor cell viability in vitro. Cancer Lett 24:165-172 (Pubitemid 14012175)
32. Imlay JA (2008) Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77:755-776
33. Juarranz A, Jaaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10:148-154
34. Juzeniene A, Moan J (2007) The history of PDT in Norway. Part one: Identification of basic mechanisms of general PDT. Photodiagnosis Photodyn Ther 4:3-11 (Pubitemid 46274564)
35. Juzeniene A, Nielsen KP, Moan J (2006) Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol 25:7-28 (Pubitemid 43341232)
36. Kalyanasundaram K (1983) Photochemistry of water-soluble porphyrins: comparative study of Isomeric tetrapyridyl- and tetrakis(NMethylpyridiniumyl) porphyrins. Inorg Chem 23:2453-2459
37. Kee HL, Bhaumik J, Diers JR, Mroz P, Hamblin MR, Bocian DF, Lindsey JS, Holten D (2008) Photophysical characterization of imidazolium-substituted Pd(II), In(III), and Zn(II) porphyrins as photosensitizers for photodynamic therapy. J Photochem Photobiol A Chem 200:346-355
38. Korshunov SS, Imlay JA (2002) A potential role for periplasmic superoxide dismutase in blocking the penetration of external superoxide into the cytosol of Gram-negative bacteria. Mol Microbiol 43:95-106 (Pubitemid 34212193)
39. Kos I, Benov L, Spasojevic I, Reboucas JS, Batinic-Haberle I (2009a) High lipophilicity of meta Mn(III) N-alkylpyridylporphyrinbased superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli. J Med Chem 52:7868-7872
40. Kos I, Reboucas JS, DeFreitas-Silva G, Salvemini D, Vujaskovic Z, Dewhirst MW, Spasojevic I, Batinic-Haberle I (2009b) Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Free Radic Biol Med 47:72-78
41. Liochev SI (1996) The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic Res 25:369-384 (Pubitemid 26379053)
42. Lledias F, Hansberg W (1999) Oxidation of human catalase by singlet oxygen in myeloid leukemia cells. Photochem Photobiol 70:887-892 (Pubitemid 129548333)
43. Lledias F, Rangel P, Hansberg W (1998) Oxidation of catalase by singlet oxygen. J Biol Chem 273:10630-10637 (Pubitemid 28227676)
44. Low PS (1986) Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochim Biophys Acta 864:145-167 (Pubitemid 16027843)
45. Luo J, Li L, Zhang Y, Spitz DR, Buettner GR, Oberley LW, Domann FE (2006) Inactivation of primary antioxidant enzymes in mouse keratinocytes by photodynamically generated singlet oxygen. Antioxid Redox Signal 8:1307-1314 (Pubitemid 44182429)
46. Lynch RE, Fridovich I (1978) Permeation of the erythrocyte stroma by superoxide radical. J Biol Chem 253:4697-4699 (Pubitemid 8372083)
47. Mikkelsen RB, Wardman P (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22:5734-5754 (Pubitemid 37176697)
48. Moan J (1990) On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol B 6:343-344
49. Moan J, Berg K (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53:549-553
50. Morgan J, Oseroff AR (2001) Mitochondria-based photodynamic anti-cancer therapy. Adv Drug Deliv Rev 49:71-86 (Pubitemid 32493801)
51. Murphy MP, Smith RAJ (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629-656
52. Nyman ES, Hynninen PH (2004) Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B 73:1-28 (Pubitemid 38145763)
53. Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633-4646 (Pubitemid 44187614)
54. Radi R (2009) Peroxynitrite and reactive nitrogen species: the contribution of ABB in two decades of research. Arch Biochem Biophys 484:111-113
55. Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 96:1-8
56. Sabirov RZ, Dutta AK, Okada Y (2001) Volume-dependent ATPconductive large-conductance anion channel as a pathway for swelling-induced ATP release. J Gen Physiol 118:251-266 (Pubitemid 32845961)
57. Salet C, Moreno G (1995) Photodynamic action increases leakage of the mitochondrial electron transport chain. Int J Radiat Biol 67:477-480
58. Silva JN, Filipe P, Morliere P, Maziere J-C, Freitas JP, Gomes MM, Santus R (2008) Photodynamic therapy: dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng 18:319-327
59. Spasojevic I, Chen Y, Noel TJ, Yu Y, Cole MP, Zhang L, Zhao Y, St. Clair DK, Batinic-Haberle I (2007) Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria. Free Radic Biol Med 42:1193-1200 (Pubitemid 46437360)
60. Spikes JD, Shen H-R, Kopeckova P, Kopecek J (1999) Photodynamic crosslinking of proteins. III. Kinetics of the FMN- and rose bengal-sensitized photooxidation and intermolecular crosslinking of model tyrosine-containing N-(2-hydroxypropyl)methacrylamide copolymers. Photochem Photobiol 70:130-137 (Pubitemid 129549200)
61. Taub AF (2007) Photodynamic therapy: other uses. Dermatol Clin 25:101-109 (Pubitemid 44780061)
62. Truscott RJW, Augusteyn RC (1977) Oxidative changes in human lens proteins during senile nuclear cataract formation. Biochim Biophys Acta 492:43-52 (Pubitemid 8106167)
63. Verweij H, Dubbelman TM, Van Steveninck J (1981) Photodynamic protein cross-linking. Biochim Biophys Acta 647:87-94
64. Waksman R, McEwan PE, Moore TI, Pakala R, Kolodgie FD, Hellinga DG, Seabron RC, Rychnovsky SJ, Vasek J, Scott RW, Virmani R (2008) Photopoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol 52:1024-1032
65. Wilkinson F, Helman WP, Ross AB (1995) Rate constants for the decay and reactions of the lowest electronically excited singlet state of molecular oxygen in solution. An expanded and revised compilation. J Phys Chem Ref Data 24:663-1021
66. Woodburn KW, Fan Q, Kessel D, Wright M, Mody TD, Hemmi G, Magda D, Sessler JL, Dow WC, Miller RA, Young SW (1996) Phototherapy of cancer and atheromatous plaque with texaphyrins. J Clin Laser Med Surg 14:343-348 (Pubitemid 26405727)